Evidence map›Paper›PMID 42626059›Full record

ArticleJournal of the Society for Cardiovascular Angiography & Interventions2026

Persistent One-Year Mortality Gradient After STEMI and COVID-19: Long-Term Outcomes From the NACMI Registry.

Payam Dehghani, Chase J Ellingson, Jyotpal Singh, Ellen Cravero, G B John Mancini, Larissa Stanberry, Mina Madan, Catherine P Benziger, Nima Ghasemzadeh, Anna E Bortnick and 19 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the Society for Cardiovascular Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Payam DehghaniPrairie Vascular Research Inc, Regina, Saskatchewan, Canada.
Chase J EllingsonPrairie Vascular Research Inc, Regina, Saskatchewan, Canada.
Jyotpal SinghPrairie Vascular Research Inc, Regina, Saskatchewan, Canada.
Ellen CraveroMinneapolis Heart Institute Foundation, Minneapolis, Minnesota.
G B John ManciniUniversity of British Columbia, Vancouver, British Columbia, Canada.
Larissa StanberryMinneapolis Heart Institute Foundation, Minneapolis, Minnesota.
Mina MadanSchulich Heart Program, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Catherine P BenzigerEssentia Health, Duluth, Minnesota.
Nima GhasemzadehGeorgia Heart Institute, Gainesville, Georgia.
Anna E BortnickMontefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York.
Rohan KankariaJohns Hopkins University School of Medicine, Department of Internal Medicine, Baltimore, Maryland.
Cindy L GrinesNorthside Hospital Cardiovascular Institute, Atlanta, Georgia.
Keshav NayakScripps Mercy Hospital, San Diego, California.
Ehtisham MahmudUniversity of California San Diego, La Jolla, California.
Kevin R BaineyCanadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
M Chadi AlraiesDetroit Medical Center, Harper University Hospital, Detroit, Michigan.
Akshay BagaiTerrence Donnelly Heart Center, St Michael's Hospital, Unity Health Network, University of Toronto, Toronto, Ontario, Canada.
Rajan A G PatelOchsner Medical Center, New Orleans, Louisiana; University of Virginia, Charlottesville, Virginia.
Shy AmlaniWilliam Osler Health System, Ontario, Canada.
Brian C CaseMedStar Heart & Vascular Institute, Washington, District of Columbia.
Ron WaksmanMedStar Heart & Vascular Institute, Washington, District of Columbia.
Jay S ShavadiaRoyal University Hospital, Saskatchewan, Canada.
Jay H StoneRWJBarnabas Health, West Orange, New Jersey.
Deepak AcharyaUniversity of Arizona, Tucson, Arizona.
Nosheen JavedCharlton Memorial Hospital, Southcoast Health, Fall River, Massachusetts.
Rodrigo BagurWestern University, Ontario, Canada.
Ross GarberichMinneapolis Heart Institute Foundation, Minneapolis, Minnesota.
Santiago GarciaThe Christ Hospital, Cincinnati, Ohio.
Timothy D HenryThe Christ Hospital, Cincinnati, Ohio.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with COVID-19 and ST-elevation myocardial infarction (STEMI) from the North American COVID-19 Myocardial Infarction (NACMI) registry had elevated in-hospital mortality compared with COVID-19-negative patients and historical controls. We examined 1-year mortality outcomes from the NACMI registry. Methods: This was a substudy of NACMI centers that participated in long-term follow-up. Patients in the NACMI registry were stratified into COVID-19-positive and COVID-19-negative groups. A historical 2018-2019 control group was derived from the Midwest STEMI Consortium registry. The primary outcome was 1-year mortality. Results: A total of 2358 STEMI patients (30% female) were included in this study, divided into 3 subgroups: COVID-19-positive (n = 623), COVID-19-negative (n = 694), and historical controls (n = 1041). One-year mortality in COVID-19-positive patients was 45% (HR, 4.88; 95% CI, 3.73-6.39; Conclusions: This study describes long-term outcomes in patients with STEMI and COVID-19. We demonstrate that the excess mortality risk associated with COVID-19 STEMI extends beyond the index hospitalization and exhibits a clear risk gradient. The cause is likely multifactorial, including pandemic-era disruptions in care, longer time-to-treatment, and the unique pathophysiology of COVID-19 STEMI.

Indexed as

coronavirusCOVID-19myocardial infarctionSTEMI

Identifiers

PMID42626059
PMCPMC13491345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.